Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Dec 7, 2014; 20(45): 17206-17217
Published online Dec 7, 2014. doi: 10.3748/wjg.v20.i45.17206
Published online Dec 7, 2014. doi: 10.3748/wjg.v20.i45.17206
Figure 2 Microsphere embolization (90Y or DEB) vs conventional transarterial chemoembolization for treatment of patients with hepatocellular carcinoma in terms of overall survival rates.
A: Meta-analysis of 1-year results; B: Meta-analysis of 2-year results; C: Meta-analysis of 3-year results. M-H: Mantel-Haenszel.
-
Citation: Ni JY, Xu LF, Wang WD, Sun HL, Chen YT. Conventional transarterial chemoembolization
vs microsphere embolization in hepatocellular carcinoma: A meta-analysis. World J Gastroenterol 2014; 20(45): 17206-17217 - URL: https://www.wjgnet.com/1007-9327/full/v20/i45/17206.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i45.17206